LB 448 – Nebraska

Status: In Process
Year Introduced: 2023
Link: https://nebraskalegislature.gov/bills/view_bill.php?DocumentID=49944

Prohibit certain provisions in a health plan in relation to clinician-administered drugs. LB 448 would prohibit an insurer from refusing to authorize, approve, or pay a participating provider for providing covered clinician administered drugs or requiring an enrollee to pay an additional fee, higher co-pay or higher coinsurance for covered clinicianadministered drugs, whether in or out of network. The bill also allows clinician-administered drugs to be provided by a pharmacy that is not in the insurers’ network.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found